The E.U.'s proposed plan to impose anti-dumping duty on imported Chinese shoes is unjust and lacks of legitimacy.

Right now, we are still in talks with South Africa and Turkey on this issue.

Meanwhile, we hope they (firms and associations) can give analyses and proposals for resolving problems.

About 60 percent of trade remedy investigation cases against China have come from developing countries like India, Turkey and South Africa.

Chinese pharmaceutical companies are seeing more anti-dumping or anti-subsidy cases. The conflicts are spreading to some major exports.

As the EU has decided to impose tentative duties on Chinese shoes, most European buyers will be cautious when they place an order.